Neuronetics, Inc. has entered into an Underwriting Agreement to sell 8 million shares of common stock at $2.25 each, expecting to raise approximately $16.355 million for general corporate purposes. The underwriter also has the option to purchase an additional 1.2 million shares within 30 days.